Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Reduces homocysteine levels
absorption-8782337 Drugs..com
Nicotinamide N-methyltransferase: a novel therapeutic target
The ability of hydroxocobalamin to rapidly scavenge and detoxify cyanide by chelation has resulted in several acute animal and human studies using systemic hydroxocobalamin doses at suprapharmacological doses as high as 140 mg/kg to support its use as an intravenous (IV) treatment for cyanide exposure
Medications know to cause bone marrow suppression (e.g., myelosuppressive antineoplastic agents) may result in a blunted or impeded response to methylcobalamin, vitamin B12 therapy
US$ 21.62
US$ 22.01
US$ 23.51
US$ 27.05
US$ 20.18
US$ 29.52
)
